Which has grown faster, BNTX or MRNA?

Over the past five years, BNTX grew revenue faster — BNTX at a 2.16% CAGR versus MRNA at -2.60%.

Which has been the better investment, BNTX or MRNA?

Over the past 5-year, BNTX delivered the higher annualized total return — BNTX at -17.39% versus MRNA at -25.58%. Past performance doesn't predict future results.

BioNTech SE (BNTX) vs Moderna, Inc. (MRNA)

BNTX leads on 9 of 9 compared metrics.

A side-by-side comparison of BioNTech SE and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — BNTX vs MRNA

growth of $100 · last 7y

BNTX +535.8%MRNA +252.5%BNTX compounded faster

BNTX MRNA

BNTX vs MRNA: by the numbers

•BNTX is the larger company ($22.90B vs $19.80B market cap).
•Both run net losses; BNTX's is the smaller (-44.73% vs -143.55% net margin).
•BNTX grew revenue faster over the past five years (2.16% vs -2.60% CAGR).

Which is better, BNTX or MRNA?

Metric tally: BNTX 9 · MRNA 0

It depends on what you're optimizing for:

GrowthBNTX(faster 5Y revenue CAGR)

QualityBNTX(higher ROIC)

Valuation

Metric	BNTX	MRNA
P/S ratio	6.97●	8.86
P/B ratio	1.06●	2.66
FCF yield	6.53%	—

Profitability

Metric	BNTX	MRNA
Gross margin	73.26%●	-13.89%
Operating margin	-51.55%●	-153.35%
Net margin	-44.73%●	-143.55%
ROE	-6.79%●	-43.12%
ROIC	-3.14%●	-29.70%

Growth (annualized)

Metric	BNTX	MRNA
Revenue CAGR (5Y)	2.16%●	-2.60%
FCF CAGR (5Y)	—	126.92%
Total return CAGR (5Y)	-17.39%●	-25.58%

Frequently asked

Which is better, BNTX or MRNA?: It depends on your goal. growth: BNTX (faster 5Y revenue CAGR); quality: BNTX (higher ROIC). Across all compared metrics, BNTX leads 9 to 0.
Which has grown faster, BNTX or MRNA?: Over the past five years, BNTX grew revenue faster — BNTX at a 2.16% CAGR versus MRNA at -2.60%.
Which has been the better investment, BNTX or MRNA?: Over the past 5-year, BNTX delivered the higher annualized total return — BNTX at -17.39% versus MRNA at -25.58%. Past performance doesn't predict future results.

Go deeper

Full BNTX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

BioNTech SE P/E ratio Moderna P/E ratio BioNTech SE dividend yield Moderna dividend yield BioNTech SE ROE Moderna ROE BioNTech SE operating margin Moderna operating margin BioNTech SE revenue growth Moderna revenue growth BioNTech SE free cash flow Moderna free cash flow

BioNTech SE & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.